Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2005 2
2006 2
2009 4
2011 1
2012 3
2013 2
2014 3
2015 2
2016 1
2017 8
2018 7
2019 12
2020 7
2021 10
2022 7
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Cancer Risk in Transgender People.
de Blok CJM, Dreijerink KMA, den Heijer M. de Blok CJM, et al. Among authors: dreijerink kma. Endocrinol Metab Clin North Am. 2019 Jun;48(2):441-452. doi: 10.1016/j.ecl.2019.02.005. Epub 2019 Mar 23. Endocrinol Metab Clin North Am. 2019. PMID: 31027551 Review.
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer.
Cejas P, Xie Y, Font-Tello A, Lim K, Syamala S, Qiu X, Tewari AK, Shah N, Nguyen HM, Patel RA, Brown L, Coleman I, Hackeng WM, Brosens L, Dreijerink KMA, Ellis L, Alaiwi SA, Seo JH, Baca S, Beltran H, Khani F, Pomerantz M, Dall'Agnese A, Crowdis J, Van Allen EM, Bellmunt J, Morrisey C, Nelson PS, DeCaprio J, Farago A, Dyson N, Drapkin B, Liu XS, Freedman M, Haffner MC, Corey E, Brown M, Long HW. Cejas P, et al. Among authors: dreijerink kma. Nat Commun. 2021 Oct 1;12(1):5775. doi: 10.1038/s41467-021-26042-z. Nat Commun. 2021. PMID: 34599169 Free PMC article.
Atypical hypocortisolism.
Dreijerink KM, Kampschreur LM, Lentjes EG, Lokhorst B, Zelissen PM. Dreijerink KM, et al. Endocr Pract. 2013 Sep-Oct;19(5):e112-4. doi: 10.4158/EP12415.CR. Endocr Pract. 2013. PMID: 23757611
Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.
Dijkman BAM, Helder D, Boogers LS, Gieles NC, van Heesewijk JO, Slaa ST, Liberton NPTJ, Wiepjes CM, de Blok CJM, den Heijer M, Dreijerink KMA. Dijkman BAM, et al. Among authors: dreijerink kma. BMC Pharmacol Toxicol. 2023 Dec 20;24(1):80. doi: 10.1186/s40360-023-00724-4. BMC Pharmacol Toxicol. 2023. PMID: 38124194 Free PMC article. Clinical Trial.
74 results